Cargando…
THE INCIDENCE OF NEW-ONSET ATRIAL FIBRILLATION IN HOSPITALIZED COVID-19 PATIENTS RECEIVING HIGH DOSE CORTICOSTEROIDS
Autores principales: | McMahan, Daniel, Patel, Aman, Jipescu, Daniel, Thambidorai, Senthil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972604/ http://dx.doi.org/10.1016/S0735-1097(22)01187-1 |
Ejemplares similares
-
EFFECT OF TOCILIZUMAB ON NEW ONSET ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS: AN UMBRELLA REVIEW
por: Patel, Aman, et al.
Publicado: (2022) -
PROGNOSTIC SIGNIFICANCE OF NEW-ONSET ATRIAL FIBRILLATION IN COVID-19
por: Ko, Darae, et al.
Publicado: (2022) -
ASSOCIATION OF NEW ONSET ATRIAL FIBRILLATION WITH ALL-CAUSE MORTALITY IN COVID 19 PATIENTS.
por: Mansoor, Kanaan, et al.
Publicado: (2022) -
VACCINE ASSOCIATED ATRIAL FIBRILLATION
por: Ghoweba, Mohamed, et al.
Publicado: (2022) -
Bi‐atrial characterization of the electrical substrate in patients with atrial fibrillation
por: Giorgios, Tsitsinakis, et al.
Publicado: (2022)